Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

Aegerion Pharmaceuticals, Inc. (AEGR)

-NasdaqGS
28.47 Down 0.24(0.84%) Jul 11, 4:00PM EDT
|After Hours : 28.20 Down 0.27 (0.95%) Jul 11, 5:50PM EDT
ProfileGet Profile for:
Aegerion Pharmaceuticals, Inc.
101 Main Street
Suite 1850
Cambridge, MA 02142
United States - Map
Phone: 617-500-7867
Fax: 617-945-7968
Website: http://www.aegerion.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:250

Business Summary 

Aegerion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies for patients with debilitating rare diseases in the United States. The company’s products include JUXTAPID (lomitapide) and LOJUXTA (lomitapide) hard capsules, an adjunct to a low-fat diet and other lipid-lowering treatments in patients with homozygous familial hypercholesterolemia. It also has the right to use lomitapide in the field of monotherapy or in combination with other dyslipidemic therapies for treatment of patients with other severe forms of hypercholesterolemia. The company distributes its product directly to patients and other purchasers through a specialty pharmacy. Aegerion Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Cambridge, Massachusetts.with other severe forms of hypercholesterolemia. The company distributes its product directly to patients and other purchasers through a specialty pharmacy. Aegerion Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Cambridge, Massachusetts.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Aegerion Pharmaceuticals, Inc.

Corporate Governance 
Aegerion Pharmaceuticals, Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 8; Compensation: 7.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Marc D. Beer , 49
Chief Exec. Officer and Director
1.16M12.20M
Mr. Mark J. Fitzpatrick , 51
Chief Financial Officer and Principal Accounting Officer
560.00K1.49M
Ms. Martha J. Carter RAC, 61
Chief Regulatory Officer and Sr. VP
495.00K339.00K
Dr. Mark Sumeray M.D., M.S., FRCS, 48
Chief Medical Officer
681.00K2.19M
Mr. Craig E. Fraser , 49
Pres of U.S. & International Commercial & Global Manufacturing and Supply Chain
651.00K1.89M
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders